Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.

Ibrahim IS, Brückner C, Carrato A, Earl J, Inderson A, de Vos Tot Nederveen Cappel WH, Mintziras I, Matthäi E, Figiel J, Wasser M, Moreau H, Bonsing B, Slater EP, Bartsch DK, Vasen HF.

United European Gastroenterol J. 2019 Jun;7(5):682-688. doi: 10.1177/2050640619841989. Epub 2019 Mar 31.

2.

Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a multicenter randomized controlled trial.

Haanstra JF, Dekker E, Cats A, Nagengast FM, Hardwick JC, Vanhoutvin SA, de Vos Tot Nederveen Cappel WH, Vasen HF, Kleibeuker JH, Koornstra JJ.

Gastrointest Endosc. 2019 Apr 24. pii: S0016-5107(19)31650-5. doi: 10.1016/j.gie.2019.04.227. [Epub ahead of print]

PMID:
31028782
3.

Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program.

Vasen HFA, Boekestijn B, Ibrahim IS, Inderson A, Bonsing BA, de Vos Tot Nederveen Cappel WH, Feshtali S, Wasser MN.

HPB (Oxford). 2019 Mar 22. pii: S1365-182X(19)30098-X. doi: 10.1016/j.hpb.2019.02.013. [Epub ahead of print]

PMID:
30910317
4.

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Seppälä TT, Ahadova A, Dominguez-Valentin M, Macrae F, Evans DG, Therkildsen C, Sampson J, Scott R, Burn J, Möslein G, Bernstein I, Holinski-Feder E, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lautrup CK, Lindblom A, Plazzer JP, Winship I, Tjandra D, Katz LH, Aretz S, Hüneburg R, Holzapfel S, Heinimann K, Valle AD, Neffa F, Gluck N, de Vos Tot Nederveen Cappel WH, Vasen H, Morak M, Steinke-Lange V, Engel C, Rahner N, Schmiegel W, Vangala D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Blanco I, Ten Broeke S, Nielsen M, Ljungmann K, Nakken S, Lindor N, Frayling I, Hovig E, Sunde L, Kloor M, Mecklin JP, Kalager M, Møller P.

Hered Cancer Clin Pract. 2019 Feb 28;17:8. doi: 10.1186/s13053-019-0106-8. eCollection 2019.

5.

Features of incident colorectal cancer in Lynch syndrome.

Argillander TE, Koornstra JJ, van Kouwen M, Langers AM, Nagengast FM, Vecht J, de Vos Tot Nederveen Cappel WH, Dekker E, van Duijvendijk P, Vasen HF.

United European Gastroenterol J. 2018 Oct;6(8):1215-1222. doi: 10.1177/2050640618783554. Epub 2018 Jun 11.

6.

Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.

Dang H, de Vos Tot Nederveen Cappel WH, van der Zwaan SMS, van den Akker-van Marle ME, van Westreenen HL, Backes Y, Moons LMG, Holman FA, Peeters KCMJ, van der Kraan J, Langers AMJ, Lijfering WM, Hardwick JCH, Boonstra JJ.

Gastrointest Endosc. 2019 Mar;89(3):533-544. doi: 10.1016/j.gie.2018.09.026. Epub 2018 Sep 28.

PMID:
30273589
7.

Pedunculated Morphology of T1 Colorectal Tumors Associates With Reduced Risk of Adverse Outcome.

Kessels K, Backes Y, Elias SG, van den Blink A, Offerhaus GJA, van Bergeijk JD, Groen JN, Seerden TCJ, Schwartz MP, de Vos Tot Nederveen Cappel WH, Spanier BWM, Geesing JMJ, Kerkhof M, Siersema PD, Didden P, Boonstra JJ, Herrero LA, Wolfhagen FHJ, Ter Borg F, van Lent AU, Terhaar Sive Droste JS, Hazen WL, Schrauwen RWM, Vleggaar FP, Laclé MM, Moons LMG; Dutch T1 Colorectal Cancer Working Group.

Clin Gastroenterol Hepatol. 2019 May;17(6):1112-1120.e1. doi: 10.1016/j.cgh.2018.08.041. Epub 2018 Aug 18.

PMID:
30130623
8.

High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers.

Ibrahim IS, Wasser MN, Wu Y, Inderson A, de Vos Tot Nederveen Cappel WH, Morreau H, Hes FJ, Veenendaal RA, Putter H, Feshtali S, van Mil AM, Gruis NA, Tollenaar RA, Bergman W, Bonsing BA, Vasen HFA.

Cancer Prev Res (Phila). 2018 Sep;11(9):551-556. doi: 10.1158/1940-6207.CAPR-18-0035. Epub 2018 Jul 10.

PMID:
29991580
9.

An unusual cause of chronic abdominal symptoms.

Brands HJ, Lupton SJ, van 't Veer-Ten Kate M, de Vos Tot Nederveen Cappel WH.

Neth J Med. 2018 Mar;76(2):92. No abstract available.

10.

Histologic Factors Associated With Need for Surgery in Patients With Pedunculated T1 Colorectal Carcinomas.

Backes Y, Elias SG, Groen JN, Schwartz MP, Wolfhagen FHJ, Geesing JMJ, Ter Borg F, van Bergeijk J, Spanier BWM, de Vos Tot Nederveen Cappel WH, Kessels K, Seldenrijk CA, Raicu MG, Drillenburg P, Milne AN, Kerkhof M, Seerden TCJ, Siersema PD, Vleggaar FP, Offerhaus GJA, Lacle MM, Moons LMG; Dutch T1 CRC Working Group.

Gastroenterology. 2018 May;154(6):1647-1659. doi: 10.1053/j.gastro.2018.01.023. Epub 2018 Jan 31.

PMID:
29366842
11.

Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).

Backes Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, Groen JN, de Vos Tot Nederveen Cappel WH, van Bergeijk J, Geesing JMJ, Spanier BWM, Didden P, Vleggaar FP, Lacle MM, Elias SG, Moons LMG; Dutch T1 CRC Working Group.

Gut. 2019 Feb;68(2):271-279. doi: 10.1136/gutjnl-2017-314723. Epub 2018 Jan 3.

PMID:
29298873
12.

Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice.

Leicher LW, Lammertink MHA, Offerman SR, Morreau H, de Jong MM, de Groot JWB, van Westreenen HL, Vasen HFA, de Vos Tot Nederveen Cappel WH.

Scand J Gastroenterol. 2018 May;53(5):632-636. doi: 10.1080/00365521.2017.1406534. Epub 2017 Nov 21.

PMID:
29161904
13.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.

Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Frayling IM, Plazzer JP, Sampson JR, Capella G, Möslein G, Mecklin JP, Møller P; Mallorca Group.

Hered Cancer Clin Pract. 2017 Oct 10;15:18. doi: 10.1186/s13053-017-0078-5. eCollection 2017.

14.

Safety of endoscopic mucosal resection (EMR) of large non-pedunculated colorectal adenomas in the elderly.

Bronsgeest K, Huisman JF, Langers A, Boonstra JJ, Schenk BE, de Vos Tot Nederveen Cappel WH, Vasen HFA, Hardwick JCH.

Int J Colorectal Dis. 2017 Dec;32(12):1711-1717. doi: 10.1007/s00384-017-2892-7. Epub 2017 Sep 8.

15.

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.

Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HFA, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Valentin MD, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Moeslein G, Sampson JR, Capella G; Mallorca Group.

Gut. 2018 Jul;67(7):1306-1316. doi: 10.1136/gutjnl-2017-314057. Epub 2017 Jul 28.

16.

Colorectal endoscopic full-thickness resection using a novel, flat-base over-the-scope clip: a prospective study.

Backes Y, Kappelle WFW, Berk L, Koch AD, Groen JN, de Vos Tot Nederveen Cappel WH, Schwartz MP, Kerkhof M, Siersema PD, Schröder R, Tan TG, Lacle MM, Vleggaar FP, Moons LMG; T1 CRC Working Group.

Endoscopy. 2017 Nov;49(11):1092-1097. doi: 10.1055/s-0043-114730. Epub 2017 Jul 28.

PMID:
28753696
17.

The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.

Backes Y, Elias SG, Bhoelan BS, Groen JN, van Bergeijk J, Seerden TCJ, Pullens HJM, Spanier BWM, Geesing JMJ, Kessels K, Kerkhof M, Siersema PD, de Vos Tot Nederveen Cappel WH, van Lelyveld N, Wolfhagen FHJ, Ter Borg F, Offerhaus GJA, Lacle MM, Moons LMG; Dutch T1 CRC Working Group.

BMC Med. 2017 Jul 14;15(1):129. doi: 10.1186/s12916-017-0892-7.

18.

Incidence of small bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy.

Haanstra JF, Al-Toma A, Dekker E, Vanhoutvin SALW, Nagengast FM, Mathus-Vliegen EM, van Leerdam ME, de Vos Tot Nederveen Cappel WH, Veenendaal RA, Cats A, Sanduleanu S, Vasen HFA, Kleibeuker JH, Koornstra JJ.

Endosc Int Open. 2017 Jul;5(7):E622-E626. doi: 10.1055/s-0043-111723. Epub 2017 Jul 6.

19.

Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis.

Ghorbanoghli Z, Bastiaansen BA, Langers AM, Nagengast FM, Poley JW, Hardwick JC, Koornstra JJ, Sanduleanu S, de Vos Tot Nederveen Cappel WH, Witteman BJ, Morreau H, Dekker E, Vasen HF.

J Med Genet. 2018 Jan;55(1):11-14. doi: 10.1136/jmedgenet-2017-104545. Epub 2017 May 10.

PMID:
28490611
20.

Spondylodiskitis after Dilatation of Esophageal Radiation Stenosis: A Suspect for Metastasis.

Stigt JA, Vossenkaul R, de Vos Tot Nederveen Cappel WH.

J Thorac Oncol. 2017 Jun;12(6):1021-1022. doi: 10.1016/j.jtho.2017.03.016. Epub 2017 Mar 27. No abstract available.

21.

Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study.

Backes Y, de Vos Tot Nederveen Cappel WH, van Bergeijk J, Ter Borg F, Schwartz MP, Spanier BWM, Geesing JMJ, Kessels K, Kerkhof M, Groen JN, Wolfhagen FHJ, Seerden TCJ, van Lelyveld N, Offerhaus GJA, Siersema PD, Lacle MM, Moons LMG.

Am J Gastroenterol. 2017 May;112(5):785-796. doi: 10.1038/ajg.2017.58. Epub 2017 Mar 21.

PMID:
28323275
22.

Limited Endoscopic-Assisted Wedge Resection for Excision of Colon Polyps.

Leicher LW, de Vos Tot Nederveen Cappel WH, van Westreenen HL.

Dis Colon Rectum. 2017 Mar;60(3):299-302. doi: 10.1097/DCR.0000000000000716.

PMID:
28177992
23.

Colonoscopy in Lynch syndrome: the need for a new quality score.

Boonstra JJ, de Vos Tot Nederveen Cappel WH, Langers AM, van der Sluis H, Hardwick JH, Vasen HF.

Fam Cancer. 2017 Apr;16(2):239-241. doi: 10.1007/s10689-016-9950-0. No abstract available.

PMID:
27830406
24.

Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.

Overwater A, Kessels K, Elias SG, Backes Y, Spanier BWM, Seerden TCJ, Pullens HJM, de Vos Tot Nederveen Cappel WH, van den Blink A, Offerhaus GJA, van Bergeijk J, Kerkhof M, Geesing JMJ, Groen JN, van Lelyveld N, Ter Borg F, Wolfhagen F, Siersema PD, Lacle MM, Moons LMG; Dutch T1 CRC Working Group.

Gut. 2018 Feb;67(2):284-290. doi: 10.1136/gutjnl-2015-310961. Epub 2016 Nov 3.

PMID:
27811313
25.

Consequences of CT colonography in stenosing colorectal cancer.

Huisman JF, Leicher LW, de Boer E, van Westreenen HL, de Groot JW, Holman FA, van de Meeberg PC, Sallevelt P, Peeters K, Wasser M, Vasen H, de Vos Tot Nederveen Cappel WH.

Int J Colorectal Dis. 2017 Mar;32(3):367-373. doi: 10.1007/s00384-016-2683-6. Epub 2016 Oct 25.

PMID:
27783161
26.

Diagnosis of T1 colorectal cancer in pedunculated polyps in daily clinical practice: a multicenter study.

Backes Y, Moons LM, Novelli MR, van Bergeijk JD, Groen JN, Seerden TC, Schwartz MP, de Vos Tot Nederveen Cappel WH, Spanier BW, Geesing JM, Kessels K, Kerkhof M, Siersema PD, Offerhaus GJ, Milne AN, Lacle MM.

Mod Pathol. 2017 Jan;30(1):104-112. doi: 10.1038/modpathol.2016.165. Epub 2016 Oct 7.

27.

Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study.

van Erp SJ, Leicher LW, Hennink SD, Ghorbanoghli Z, Breg SA, Morreau H, Nielsen M, Hardwick JC, Roukema JA, Langers AM, de Vos Tot Nederveen Cappel WH, Vasen HF.

Scand J Gastroenterol. 2016 Oct;51(10):1227-32. doi: 10.1080/00365521.2016.1193219. Epub 2016 Jun 16.

28.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Möslein G, Sampson JR, Capella G; Mallorca Group (http://mallorca-group.org).

Gut. 2017 Sep;66(9):1657-1664. doi: 10.1136/gutjnl-2016-311403. Epub 2016 Jun 3.

29.

Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trial.

Backes Y, Moons LM, van Bergeijk JD, Berk L, Ter Borg F, Ter Borg PC, Elias SG, Geesing JM, Groen JN, Hadithi M, Hardwick JC, Kerkhof M, Mangen MJ, Straathof JW, Schröder R, Schwartz MP, Spanier BW, de Vos Tot Nederveen Cappel WH, Wolfhagen FH, Koch AD.

BMC Gastroenterol. 2016 May 26;16(1):56. doi: 10.1186/s12876-016-0468-6.

30.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
31.

Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.

Vasen HF, Velthuizen ME, Kleibeuker JH, Menko FH, Nagengast FM, Cats A, van der Meulen-de Jong AE, Breuning MH, Roukema AJ, van Leeuwen-Cornelisse I, de Vos Tot Nederveen Cappel WH, Wijnen JT.

Fam Cancer. 2016 Jul;15(3):429-35. doi: 10.1007/s10689-016-9897-1.

32.

Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer.

Soer EC, Leicher LW, Langers AM, van de Meeberg PC, van der Wouden EJ, Koornstra JJ, Bigirwamungu-Bargeman M, Vasen HF, de Vos tot Nederveen Cappel WH.

Int J Colorectal Dis. 2016 Mar;31(3):693-7. doi: 10.1007/s00384-016-2524-7. Epub 2016 Feb 4.

PMID:
26847620
33.

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Sampson JR, Capella G, Mecklin JP, Möslein G; Mallorca Group (http://mallorca-group.eu).

Gut. 2017 Mar;66(3):464-472. doi: 10.1136/gutjnl-2015-309675. Epub 2015 Dec 9.

34.

Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer.

Hennink SD, van der Meulen-de Jong AE, Wolterbeek R, Crobach AS, Becx MC, Crobach WF, van Haastert M, Ten Hove WR, Kleibeuker JH, Meijssen MA, Nagengast FM, Rijk MC, Salemans JM, Stronkhorst A, Tuynman HA, Vecht J, Verhulst ML, de Vos Tot Nederveen Cappel WH, Walinga H, Weinhardt OK, Westerveld D, Witte AM, Wolters HJ, Cats A, Veenendaal RA, Morreau H, Vasen HF.

J Clin Oncol. 2015 Dec 10;33(35):4188-93. doi: 10.1200/JCO.2015.62.2035. Epub 2015 Nov 2.

PMID:
26527788
35.

Massive gastric polyposis associated with a germline SMAD4 gene mutation.

Soer E, de Vos Tot Nederveen Cappel WH, Ligtenberg MJ, Moll F, Pierik RG, Vecht J, Vasen HF, Flierman A.

Fam Cancer. 2015 Dec;14(4):569-73. doi: 10.1007/s10689-015-9822-z.

PMID:
26159157
36.

Comparison of cecal intubation and adenoma detection between hospitals can provide incentives to improve quality of colonoscopy.

Belderbos TD, Grobbee EJ, van Oijen MG, Meijssen MA, Ouwendijk RJ, Tang TJ, ter Borg F, van der Schaar P, Le Fèvre DM, Stouten MT, van der Galiën O, Hiemstra TJ, de Vos tot Nederveen Cappel WH, ter Borg PC, Spaander MC, Moons LM, Kuipers EJ, Siersema PD.

Endoscopy. 2015 Aug;47(8):703-9. doi: 10.1055/s-0034-1391968. Epub 2015 Jun 19.

PMID:
26090725
37.

Predicting inadequate bowel preparation for colonoscopy in participants receiving split-dose bowel preparation: development and validation of a prediction score.

Dik VK, Moons LM, Hüyük M, van der Schaar P, de Vos Tot Nederveen Cappel WH, Ter Borg PC, Meijssen MA, Ouwendijk RJ, Le Fèvre DM, Stouten M, van der Galiën O, Hiemstra TJ, Monkelbaan JF, van Oijen MG, Siersema PD; Colonoscopy Quality Initiative.

Gastrointest Endosc. 2015 Mar;81(3):665-72. doi: 10.1016/j.gie.2014.09.066. Epub 2015 Jan 17.

PMID:
25600879
38.

Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.

Potjer TP, Kranenburg HE, Bergman W, de Vos tot Nederveen Cappel WH, van Monsjou HS, Barge-Schaapveld DQ, Vasen HF.

Eur J Hum Genet. 2015 May;23(5):711-4. doi: 10.1038/ejhg.2014.187. Epub 2014 Sep 17.

39.

Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy.

Haanstra JF, Al-Toma A, Dekker E, Vanhoutvin SA, Nagengast FM, Mathus-Vliegen EM, van Leerdam ME, de Vos tot Nederveen Cappel WH, Sanduleanu S, Veenendaal RA, Cats A, Vasen HF, Kleibeuker JH, Koornstra JJ.

Gut. 2015 Oct;64(10):1578-83. doi: 10.1136/gutjnl-2014-307348. Epub 2014 Sep 10.

PMID:
25209657
40.

Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer.

Bisschop C, Tjalma JJ, Hospers GA, Van Geldere D, de Groot JW, Wiegman EM, Van't Veer-Ten Kate M, Havenith MG, Vecht J, Beukema JC, Kats-Ugurlu G, Mahesh SV, van Etten B, Havenga K, Burgerhof JG, de Groot DJ, de Vos Tot Nederveen Cappel WH.

Ann Surg Oncol. 2015 Feb;22(2):552-6. doi: 10.1245/s10434-014-3996-8. Epub 2014 Aug 26.

PMID:
25155395
41.

Quality colonoscopy and risk of interval cancer in Lynch syndrome.

Haanstra JF, Vasen HF, Sanduleanu S, van der Wouden EJ, Koornstra JJ, Kleibeuker JH, de Vos Tot Nederveen Cappel WH.

Int J Colorectal Dis. 2013 Dec;28(12):1643-9. doi: 10.1007/s00384-013-1745-2. Epub 2013 Jul 16.

PMID:
23857598
42.

Value-based healthcare in Lynch syndrome.

Hennink SD, Hofland N, Gopie JP, van der Kaa C, de Koning K, Nielsen M, Tops C, Morreau H, de Vos tot Nederveen Cappel WH, Langers AM, Hardwick JC, Gaarenstroom KN, Tollenaar RA, Veenendaal RA, Tibben A, Wijnen J, van Heck M, van Asperen C, Roukema AJ, Hommes DW, Hes FJ, Vasen HF.

Fam Cancer. 2013 Jun;12(2):347-54. doi: 10.1007/s10689-013-9655-6.

PMID:
23681793
43.

A hundred years of Lynch syndrome research (1913-2013).

Vasen HF, de Vos Tot Nederveen Cappel WH.

Fam Cancer. 2013 Jun;12(2):141-2. doi: 10.1007/s10689-013-9654-7. No abstract available.

PMID:
23670342
44.

Colorectal surveillance in Lynch syndrome families.

de Vos tot Nederveen Cappel WH, Järvinen HJ, Lynch PM, Engel C, Mecklin JP, Vasen HF.

Fam Cancer. 2013 Jun;12(2):261-5. doi: 10.1007/s10689-013-9631-1. Review.

PMID:
23525799
45.

Esophageal fistula after EUS-FNA in a patient treated with bevacizumab for non-small-cell lung cancer.

Stigt JA, Boomsma MF, de Vos tot Nederveen Cappel WH.

J Thorac Oncol. 2013 Mar;8(3):e25-6. doi: 10.1097/JTO.0b013e318282e029. No abstract available.

46.

Variation in precursor lesions of pancreatic cancer among high-risk groups.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK; Leiden Familial Pancreatic Cancer Group; FaPaCa registry.

Clin Cancer Res. 2013 Jan 15;19(2):442-9. doi: 10.1158/1078-0432.CCR-12-2730. Epub 2012 Nov 21.

47.

Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy.

Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP, Vecht J, Vanhoutvin SA, Cats A, van der Zaag-Loonen HJ, Langers AM, Bergmann JH, van de Meeberg PC, Dekker E, Kleibeuker JH, Vasen HF, Nagengast FM, van Duijvendijk P.

Dis Colon Rectum. 2012 Jun;55(6):653-9. doi: 10.1097/DCR.0b013e31824f5392.

PMID:
22595844
48.

Two patients with extremely elevated tumor markers: where is the malignancy?

van der Veek PP, de Vos Tot Nederveen Cappel WH, Langers AM, van Hoek B.

Gastroenterol Res Pract. 2011;2011:123743. doi: 10.1155/2011/123743. Epub 2011 Jun 16.

49.

Cancer: Lynch syndrome--how should colorectal cancer be managed?

Vasen HF, de Vos tot Nederveen Cappel WH.

Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):184-6. doi: 10.1038/nrgastro.2011.34.

PMID:
21460875
50.

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

Vasen HF, Wasser M, van Mil A, Tollenaar RA, Konstantinovski M, Gruis NA, Bergman W, Hes FJ, Hommes DW, Offerhaus GJ, Morreau H, Bonsing BA, de Vos tot Nederveen Cappel WH.

Gastroenterology. 2011 Mar;140(3):850-6. doi: 10.1053/j.gastro.2010.11.048. Epub 2010 Dec 1.

PMID:
21129377

Supplemental Content

Loading ...
Support Center